Nootropics: The Silicon Valley pills used to boost performance

Nootropics: The cocktail Silicon Valley uses to boost productivity

Smart drugs exist, they are sold, and they are taken. Whether they actually work is another matter. The concept is not new: in 1972, Romanian psychologist Corneliu E. Giurgea synthesized piracetam and established the rules—substances that would improve learning, mood, and memory without being toxic or addictive—concluding with a phrase that sums up the era's ambition: "Man is not going to wait millions of years for evolution to offer him a better brain." Impatience elevated to a pharmacological category.

The Silicon Valley version trinc a breakfast ritual. Next to the cup, a few pills, ampoules, or dropper bottles. A bit of piracetam, some deanol, or a ginkgo infusion instead of milk. Each person adjusts their mix over weeks, monitoring mood and concentration until they find the combination that, in theory, triggers the next million-dollar idea.

From Nootrobox to Monday-to-Wednesday fasting

The business is already up and running. Nootrobox sells omega-3 treats and caffeine cubes, and its founder, Geoffrey Woo, describes the effect as a mix of "concentration, vigor, and endurance" capable of keeping the engine running throughout the entire workday. Before selling anything, the team exposed themselves to the compounds: they discovered nootropics through biohackers in online communities, reviewed clinical data, and began testing their own combinations.

The company added a practice to its culture that is hardly pharmacological: weekly fasting. From Monday night to Wednesday, no eating. The idea came from an employee in late 2015 and seeks to induce a state of ketosis that forces the body to burn accumulated fat as fuel. On Wednesday morning, a hearty breakfast and a return to the routine. Woo calls it the next frontier of our evolution.

The real catalog: theanine, rhodiola, and modafinil

Beyond the brand brochure, what is actually bought and tested is a disorganized drawer: L-theanine, rhodiola rosea, inositol, phosphatidylserine, N-acetyl-L-tyrosine, choline bitartrate, sulbutiamine, 5-HTP, alpha-lipoic acid, B vitamins, and high-quality omega-3. The most cited are noopept and phenylpiracetam of Russian origin, and above all, modafinil.

There is a recurring argument to downplay the issue: many of these substances are already ingested with food. Deanol, or DMAE, is found in sardines and anchovies. The difference is the dosage: what is sold in powder is the isolated and concentrated compound. Proponents insist it is not doping, but rather nutrition with the volume turned up.

Why do some feel the rush while others feel nothing?

The most common answer is uncomfortable for the seller: it depends on the person. It is argued that those who already subject their brain to daily training, or work in intellectually demanding professions, barely perceive the stimulus; the margin for improvement is small because the starting point is already high. Those starting from a lower level, however, may find the effect notable.

There are also those who attribute lack of motivation to caffeine tolerance and propose milder alternatives. It doesn't always work. One testimony from the summer of 2016 summarized the experience with two star products from the catalog: "I tried theanine and caffeine and nothing at all, a waste of money."

High blood pressure, insomnia, and an unregulated market

The dark side of the brochure exists. One consumer reported combining noopept, powdered deanol, choline, and omega-3 daily and ended up throwing it all away because their blood pressure rose "insanely". They admitted feeling "more lucid, stronger, and better," but without measuring their blood pressure, they might have exploded. Other cases reported by specialized press speak of headaches, insomnia, anxiety, and depression. Nootrobox insists they work with compounds that have a very low side-effect profile.

The underlying problem is regulatory. According to one participant, noopept was discovered in Russia and lacks endorsement from the FDA or European medicine agencies, fueling suspicions regarding its safety studies. According to another, piracetam is available in Spanish pharmacies as Nootropil, but is not funded by the Spanish Social Security (the public healthcare system) due to questionable efficacy. Powerful drugs and banned substances are also mixed in, such as yohimbine, which one consumer claimed to have received without issue, despite another participant warning that it is banned in Spain.

Logistics also pose a challenge. When a regular supplier stopped shipping to Spain, buyers had to look for alternatives through European distributors and sports supplementation websites.

The frontier: modafinil, Rubifén, and ALUCINÓGENO ILEGAL microdosing

Modafinil, prescribed for narcolepsy, is the favorite among technical profiles. An IT professional described it this way: "for work like mine, you notice a notable boost in concentration and productivity," using a pattern of two weeks of use trinc by months of rest. Rubifén and Concerta are prescription drugs; some describe them as amphetamines.

In parallel, interest is growing in ALUCINÓGENO ILEGAL and mushroom microdosing to gain creativity without a hallucinogenic alucinación. The more orthodox community rejects it: it does not meet Giurgea's definition, because a nootropic, by definition, must not cause addiction or intoxication. Others respond by reminding them that Newton, Leibniz, Gauss, Euler, and Maxwell did not take any of this and developed infinitesimal calculus and electromagnetism. Silicon Valley, with all its cocktail, has given birth to Facebook, Instagram, and a mobile bug-catching game.

With the available evidence, the smart drug market will continue to grow faster than any study capable of validating it, and the buyer will continue to pay for a promise measured in IQ points that no one has verified. If clinical research ever catches up with demand, perhaps we will know which half of the rush is chemistry and which half is faith. Until then, everyone experiments with their brain and their blood pressure.

---